Cargando…

Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro‐Fibrotic Signaling

BACKGROUND: Experimental uremic cardiomyopathy causes cardiac fibrosis and is causally related to the increased circulating levels of the cardiotonic steroid, marinobufagenin (MBG), which signals through Na/K‐ATPase. Rapamycin is an inhibitor of the serine/threonine kinase mammalian target of rapamy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haller, Steven T., Yan, Yanling, Drummond, Christopher A., Xie, Joe, Tian, Jiang, Kennedy, David J., Shilova, Victoria Y., Xie, Zijian, Liu, Jiang, Cooper, Christopher J., Malhotra, Deepak, Shapiro, Joseph I., Fedorova, Olga V., Bagrov, Alexei Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121507/ https://www.ncbi.nlm.nih.gov/pubmed/27694325 http://dx.doi.org/10.1161/JAHA.116.004106

Ejemplares similares

Gender differences in the development of uremic cardiomyopathy following partial nephrectomy: Role of progesterone
por: Drummond, Christopher A, et al.
Publicado: (2013)

Dietary Sodium Restriction Reduces Arterial Stiffness, Vascular TGF-β-Dependent Fibrosis and Marinobufagenin in Young Normotensive Rats
por: Grigorova, Yulia N., et al.
Publicado: (2018)

Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia
por: Fedorova, Olga V., et al.
Publicado: (2018)

Effect of Cardiotonic Steroid Marinobufagenin on Vascular Remodeling and Cognitive Impairment in Young Dahl-S Rats
por: Grigorova, Yulia N., et al.
Publicado: (2022)

Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia
por: Agalakova, Natalia I., et al.
Publicado: (2022)

Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension
por: Zhang, Yongqing, et al.
Publicado: (2019)

Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy
por: Liu, Jiang, et al.
Publicado: (2016)

Corrigendum: Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy
por: Liu, Jiang, et al.
Publicado: (2017)

Marinobufagenin Inhibits Neutrophil Migration and Proinflammatory Cytokines
por: Carvalho, Deyse C. M., et al.
Publicado: (2019)

Silencing of PKG1 Gene Mimics Effect of Aging and Sensitizes Rat Vascular Smooth Muscle Cells to Cardiotonic Steroids: Impact on Fibrosis and Salt Sensitivity
por: Fedorova, Olga V., et al.
Publicado: (2023)

The Cardiotonic Steroid Marinobufagenin Is a Predictor of Increased Left Ventricular Mass in Obesity: The African-PREDICT Study
por: Strauss-Kruger, Michél, et al.
Publicado: (2020)

Influence of Endogenous Cardiac Glycosides, Digoxin, and Marinobufagenin in the Physiology of Epithelial Cells
por: Ogazon del Toro, Alejandro, et al.
Publicado: (2019)

Genetic Control of Serum Marinobufagenin in the Spontaneously Hypertensive Rat and the Relationship to Blood Pressure
por: Dmitrieva, Renata I., et al.
Publicado: (2017)

New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases
por: Carullo, Nazareno, et al.
Publicado: (2023)

Marinobufagenin, Left Ventricular Hypertrophy and Residual Renal Function in Kidney Transplant Recipients
por: Bolignano, Davide, et al.
Publicado: (2023)

Comparison of Neurocognitive Testing and the Measurement of Marinobufagenin in Mild Traumatic Brain Injury: A Preliminary Report
por: Oliver, Joel, et al.
Publicado: (2015)

Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study
por: Bolignano, Davide, et al.
Publicado: (2023)

Ca(2+)-Driven Selectivity of the Effect of the Cardiotonic Steroid Marinobufagenin on Rabbit Sinoatrial Node Function
por: Segal, Sofia, et al.
Publicado: (2023)

Comparison of Digitalis Sensitivities of Na(+)/K(+)-ATPases from Human and Pig Kidneys
por: Gable, Marjorie E., et al.
Publicado: (2017)

Protein Carbonylation of an Amino Acid Residue of the Na/K‐ATPase α1 Subunit Determines Na/K‐ATPase Signaling and Sodium Transport in Renal Proximal Tubular Cells
por: Yan, Yanling, et al.
Publicado: (2016)

The Redox-Sensitive Na/K-ATPase Signaling in Uremic Cardiomyopathy
por: Liu, Jiang, et al.
Publicado: (2020)

Impairing the production of ribosomal RNA activates mammalian target of rapamycin complex 1 signalling and downstream translation factors
por: Liu, Rui, et al.
Publicado: (2014)

The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension
por: Keppel, Martin H., et al.
Publicado: (2019)

Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
por: Chen, Xueying, et al.
Publicado: (2023)

Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells
por: Molina-Molina, M., et al.
Publicado: (2018)

Uremic frost
por: Mathur, Mohit, et al.
Publicado: (2014)

A strategic expression method of miR-29b and its anti-fibrotic effect based on RNA-sequencing analysis
por: Fan, Xiaoming, et al.
Publicado: (2020)

Marinobufagenin inhibits glioma growth through sodium pump α1 subunit and ERK signaling‐mediated mitochondrial apoptotic pathway
por: Lan, Yu‐Long, et al.
Publicado: (2018)

The Effects of Short-Term Changes in Sodium Intake on Plasma Marinobufagenin Levels in Patients with Primary Salt-Sensitive and Salt-Insensitive Hypertension
por: Łabno-Kirszniok, Katarzyna, et al.
Publicado: (2021)

Longevity, aging and rapamycin
por: Ehninger, Dan, et al.
Publicado: (2014)

The Drosophila FoxA Ortholog Fork Head Regulates Growth and Gene Expression Downstream of Target of Rapamycin
por: Bülow, Margret H., et al.
Publicado: (2010)

Abnormal respiratory progenitors in fibrotic lung injury
por: Xie, Ting, et al.
Publicado: (2022)

Paracrine Factors in Uremic Cardiomyopathy
por: Sucharov, Carmen C.
Publicado: (2020)

Correction to: Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension
Publicado: (2022)

Effect of Different Hemodialysis Methods on Microbiota in Uremic Patients
por: He, Haidong, et al.
Publicado: (2020)

Left ventricular shape predicts arrhythmic risk in fibrotic dilated cardiomyopathy
por: Balaban, Gabriel, et al.
Publicado: (2021)

Therapeutic effects of rapamycin on alcoholic cardiomyopathy
por: Tu, Xilin, et al.
Publicado: (2017)

T(1) and T(2) Mapping in Uremic Cardiomyopathy: An Update
por: Arcari, Luca, et al.
Publicado: (2022)

Impact of nocturnal hemodialysis on peripheral uremic neuropathy
por: Ghazan-Shahi, Sassan, et al.
Publicado: (2015)

Eukaryotic Initiation Factor 2α - a Downstream Effector of Mammalian Target of Rapamycin - Modulates DNA Repair and Cancer Response to Treatment
por: Tuval-Kochen, Liron, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lf2p1g8593klmqpinbm8jf0b6m